Literature DB >> 26179127

Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease.

M Deforest1, J Grabell2, S Albert1, J Young1, A Tuttle1, W M Hopman3,4, P D James1,2.   

Abstract

INTRODUCTION/AIM: Our aim was to generate, optimize and validate a self-administered bleeding assessment tool (self-BAT) for von Willebrand disease (VWD).
METHODS: In Phase 1, medical terminology in the expert-administered International Society on Thrombosis and Haemostasis (ISTH)-BAT was converted into a Grade 4 reading level to produce the first version of the Self-BAT which was then optimized to ensure agreement with the ISTH-BAT. In Phase 2, the normal range of bleeding scores (BSs) was determined and test-retest reliability analysed. In Phase 3, the optimized Self-BAT was tested as a screening tool for first time referrals to the Haematology clinic.
RESULTS: Bleeding score from the final optimized version of the Self-BAT showed an excellent intra-class correlation coefficient (ICC) of 0.87 with ISTH-BAT BS in Phase 1. In Phase 2, the normal range of BSs for the optimized Self-BAT was determined to be 0 to +5 for females and 0 to +3 for males and excellent test-retest reliability was shown (ICC = 0.95). In Phase 3, we showed that a positive Self-BAT BS (≥6 for females, ≥4 for males) has a sensitivity of 78%, specificity of 23%, positive predictive value (PPV) of 0.15 and negative predictive value (NPV) of 0.86 for VWD; these figures improved when just the females were analysed; sensitivity of 100%, specificity of 21%, PPV = 0.17 and NPV = 1.0.
CONCLUSION: We show an optimized Self-BAT can generate comparable BS to the expert-administered ISTH-BAT and is a reliable, effective screening tool to incorporate into the assessment of individuals, particularly women, referred for a possible bleeding disorder.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  bleeding assessment tools; inherited bleeding disorders; symptom assessment; von Willebrand disease

Mesh:

Year:  2015        PMID: 26179127      PMCID: PMC4696512          DOI: 10.1111/hae.12747

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  10 in total

1.  A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).

Authors:  A Tosetto; F Rodeghiero; G Castaman; A Goodeve; A B Federici; J Batlle; D Meyer; E Fressinaud; C Mazurier; J Goudemand; J Eikenboom; R Schneppenheim; U Budde; J Ingerslev; Z Vorlova; D Habart; L Holmberg; S Lethagen; J Pasi; F Hill; I Peake
Journal:  J Thromb Haemost       Date:  2006-04       Impact factor: 5.824

2.  The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study.

Authors:  F Rodeghiero; G Castaman; A Tosetto; J Batlle; F Baudo; A Cappelletti; P Casana; N De Bosch; J C J Eikenboom; A B Federici; S Lethagen; S Linari; A Srivastava
Journal:  J Thromb Haemost       Date:  2005-12       Impact factor: 5.824

3.  Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines.

Authors:  William L Nichols; Margaret E Rick; Thomas L Ortel; Robert R Montgomery; J Evan Sadler; Barbara P Yawn; Andra H James; Mae B Hultin; Marilyn J Manco-Johnson; Mark Weinstein
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047

4.  ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders.

Authors:  F Rodeghiero; A Tosetto; T Abshire; D M Arnold; B Coller; P James; C Neunert; D Lillicrap
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

5.  A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population.

Authors:  M Bowman; W M Hopman; D Rapson; D Lillicrap; M Silva; P James
Journal:  Pediatr Blood Cancer       Date:  2010-07-15       Impact factor: 3.167

6.  Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire.

Authors:  T T Biss; V S Blanchette; D S Clark; M Bowman; C D Wakefield; M Silva; D Lillicrap; P D James; M L Rand
Journal:  J Thromb Haemost       Date:  2010-02-02       Impact factor: 5.824

7.  Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease.

Authors:  M Bowman; G Mundell; J Grabell; W M Hopman; D Rapson; D Lillicrap; P James
Journal:  J Thromb Haemost       Date:  2008-10-04       Impact factor: 5.824

Review 8.  Clinical diagnosis of von Willebrand disease.

Authors:  A B Federici
Journal:  Haemophilia       Date:  2004-10       Impact factor: 4.287

9.  The effect of exercise on von Willebrand factor and ADAMTS-13 in individuals with type 1 and type 2B von Willebrand disease.

Authors:  J Stakiw; M Bowman; C Hegadorn; C Pruss; C Notley; E Groot; P J Lenting; D Rapson; D Lillicrap; P James
Journal:  J Thromb Haemost       Date:  2007-10-08       Impact factor: 5.824

10.  Normal range of bleeding scores for the ISTH-BAT: adult and pediatric data from the merging project.

Authors:  M Elbatarny; S Mollah; J Grabell; S Bae; M Deforest; A Tuttle; W Hopman; D S Clark; A C Mauer; M Bowman; J Riddel; P A Christopherson; R R Montgomery; M L Rand; B Coller; P D James
Journal:  Haemophilia       Date:  2014-09-06       Impact factor: 4.287

  10 in total
  12 in total

1.  New advances in the diagnosis of von Willebrand disease.

Authors:  Ruchika Sharma; Sandra L Haberichter
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 2.  Women and bleeding disorders: diagnostic challenges.

Authors:  Paula D James
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 3.  New developments in von Willebrand disease.

Authors:  Helen Fogarty; Dearbhla Doherty; James S O'Donnell
Journal:  Br J Haematol       Date:  2020-05-12       Impact factor: 6.998

4.  ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.

Authors:  Paula D James; Nathan T Connell; Barbara Ameer; Jorge Di Paola; Jeroen Eikenboom; Nicolas Giraud; Sandra Haberichter; Vicki Jacobs-Pratt; Barbara Konkle; Claire McLintock; Simon McRae; Robert R Montgomery; James S O'Donnell; Nikole Scappe; Robert Sidonio; Veronica H Flood; Nedaa Husainat; Mohamad A Kalot; Reem A Mustafa
Journal:  Blood Adv       Date:  2021-01-12

5.  Use of electronic self-administered bleeding assessment tool in diagnosis of paediatric bleeding disorders.

Authors:  Dominder Kaur; Bryce A Kerlin; Joseph R Stanek; Sarah H O'Brien
Journal:  Haemophilia       Date:  2021-06-05       Impact factor: 4.263

6.  Risk factors for bleeding in haemato-oncology patients-a nested case-control study: The BITE study protocol (Bleeding In Thrombocytopenia Explained).

Authors:  Loes L Cornelissen; Camila Caram-Deelder; Johanna G van der Bom; Rutger A Middelburg; Jaap Jan Zwaginga
Journal:  BMJ Open       Date:  2020-06-30       Impact factor: 2.692

7.  Predictive value of a bleeding score for postpartum hemorrhage.

Authors:  Ada Gillissen; Thomas van den Akker; Camila Caram-Deelder; Dacia D C A Henriquez; Sebastiaan W A Nij Bijvank; Kitty W M Bloemenkamp; Jeroen Eikenboom; Johanna G van der Bom
Journal:  Res Pract Thromb Haemost       Date:  2019-04-04

8.  Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms.

Authors:  Jordan Spradbrow; Sasha Letourneau; Julie Grabell; Yupu Liang; James Riddel; Wilma Hopman; Victor S Blanchette; Margaret L Rand; Barry S Coller; Andrew D Paterson; Paula D James
Journal:  Res Pract Thromb Haemost       Date:  2019-10-30

9.  Bone health in symptomatic carriers of haemophilia A: a protocol for a multicentre prospective matched-cohort study.

Authors:  Grace H Tang; Erin Norris; Jessica Petrucci; Paula D James; Adrienne Lee; Man-Chiu Poon; Georgina Floros; Laurence Boma-Fischer; Jerry Teitel; Rosane Nisenbaum; Michelle Sholzberg
Journal:  BMJ Open       Date:  2019-12-02       Impact factor: 2.692

10.  Reliability and Feasibility of the Self-Administered ISTH-Bleeding Assessment Tool.

Authors:  Marieke C Punt; Maaike W Blaauwgeers; Merel A Timmer; Paco M J Welsing; Roger E G Schutgens; Karin P M van Galen
Journal:  TH Open       Date:  2019-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.